During the past decade, Clinical Alliance for Research & Education - Infectious Diseases, LLC (CARE-ID) conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 12 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Alliance for Research & Education - Infectious Diseases, LLC (CARE-ID)" #1 sponsor was "Gilead Sciences" with 13 trials, followed by "Pfizer" with 3 trials sponsored, "BioNTech SE" with 2 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored and "Clinical Alliance for Research & Education - Infectious Diseases, LLC." with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Alliance for Research & Education - Infectious Diseases, LLC (CARE-ID)" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "Cubist Pharmaceuticals LLC" with 1 trials as a collaborator and "Janssen Research & Development, LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Alliance for Research & Education - Infectious Diseases, LLC (CARE-ID)" are "HIV Infections" (8 trials), "HIV" (5 trials), "HIV-1 Infection" (3 trials), "Acquired Immunodeficiency Syndrome" (2 trials) and "COVID-19" (2 trials). Many other conditions were trialed in "Clinical Alliance for Research & Education - Infectious Diseases, LLC (CARE-ID)" in a lesser frequency.

Most popular intervention types in "Clinical Alliance for Research & Education - Infectious Diseases, LLC (CARE-ID)" are "Drug" (15 trials), "Biological" (8 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "E/C/F/TAF" (4 trials), "E/C/F/TDF" (3 trials), "ATV" (2 trials) and "BNT162b2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Alliance for Research & Education - Infectious Diseases, LLC (CARE-ID)" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Alliance for Research & Education - Infectious Diseases, LLC (CARE-ID)". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Clinical Alliance for Research & Education - Infectious Diseases, LLC (CARE-ID), undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Alliance for Research & Education - Infectious Diseases, LLC (CARE-ID), 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".